Six-Month shot tested to control advanced prostate cancer

NCT ID NCT05590793

Summary

This study tested a long-acting, 6-month injection (triptorelin) for Chinese men with advanced prostate cancer that has spread or is locally advanced. The main goal was to see if a single injection could safely and effectively lower testosterone to very low levels, which helps control the cancer. Researchers measured testosterone levels and side effects in 195 participants over 24 weeks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Hospital of Hebei University

    Baoding, China

  • Beijing Hospital

    Beijing, China

  • Chongqing University Cancer Hospital

    Chongqing, China

  • Deyang People's Hospital

    Deyang, China

  • Fudan University Shang Hai Cancer Center

    Shanghai, China

  • Guizhou Provincial People's Hospital

    Guiyang, China

  • Henan Cancer Hospital

    Zhengzhou, China

  • Hunan Cancer Hospital

    Changsha, China

  • Liaoning Cancer Hospital & Institute

    Shenyang, China

  • Nanjing Drum Tower Hospital

    Nanjing, China

  • Ningbo First Hospital

    Ningbo, China

  • Northern Jiangsu People's Hospital

    Yangzhou, China

  • Peking University First Hospital

    Beijing, China

  • Peking University People's Hospital

    Beijing, China

  • Peking University Shenzhen Hospital

    Shenzhen, China

  • Qilu Hospital of Shandong University

    Jinan, China

  • Shandong Provincial Hospital

    Jinan, China

  • Shanghai Fifth People's Hospital

    Shanghai, China

  • Shanghai Tongji Hospital

    Shanghai, China

  • Subei People's Hospital

    Yangzhou, China

  • Suining Central Hospital

    Suining, China

  • Sun Yat-Sen University Cancer Center

    Guangzhou, China

  • The Affiliated Hospital of Guizhou Medical University

    Guiyang, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, China

  • The First Affiliated Hospital of Wannan Medical College

    Wuhu, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, China

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, China

  • The First Hospital of China Medical University

    Shenyang, China

  • The Second Affiliated Hospital of Soochow University

    Suzhou, China

  • The Second Affiliated Hospital of Wannan Medical College

    Wuhu, China

  • Tianjin Cancer Hospital

    Tianjin, China

  • West China Hospital of Sichuan University

    Chengdu, China

  • Wuxi People's Hospital

    Wuxi, China

  • Yantai Yuhuangding Hospital

    Yantai, China

  • Zhongda Hospital Southeast University

    Nanjing, China

  • Zigong First People's Hospital

    Zigong, China

Conditions

Explore the condition pages connected to this study.